Cargando…
Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135690/ https://www.ncbi.nlm.nih.gov/pubmed/30220979 http://dx.doi.org/10.18632/oncotarget.26066 |
_version_ | 1783354861293666304 |
---|---|
author | Mellai, Marta Cattaneo, Monica Storaci, Alessandra Maria Annovazzi, Laura Cassoni, Paola Melcarne, Antonio De Blasio, Pasquale Schiffer, Davide Biunno, Ida |
author_facet | Mellai, Marta Cattaneo, Monica Storaci, Alessandra Maria Annovazzi, Laura Cassoni, Paola Melcarne, Antonio De Blasio, Pasquale Schiffer, Davide Biunno, Ida |
author_sort | Mellai, Marta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6135690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-61356902018-09-14 Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy Mellai, Marta Cattaneo, Monica Storaci, Alessandra Maria Annovazzi, Laura Cassoni, Paola Melcarne, Antonio De Blasio, Pasquale Schiffer, Davide Biunno, Ida Oncotarget Correction Impact Journals LLC 2018-08-24 /pmc/articles/PMC6135690/ /pubmed/30220979 http://dx.doi.org/10.18632/oncotarget.26066 Text en Copyright: © 2018 Mellai et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Mellai, Marta Cattaneo, Monica Storaci, Alessandra Maria Annovazzi, Laura Cassoni, Paola Melcarne, Antonio De Blasio, Pasquale Schiffer, Davide Biunno, Ida Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title | Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title_full | Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title_fullStr | Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title_full_unstemmed | Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title_short | Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
title_sort | correction: sel1l snp rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135690/ https://www.ncbi.nlm.nih.gov/pubmed/30220979 http://dx.doi.org/10.18632/oncotarget.26066 |
work_keys_str_mv | AT mellaimarta correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT cattaneomonica correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT storacialessandramaria correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT annovazzilaura correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT cassonipaola correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT melcarneantonio correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT deblasiopasquale correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT schifferdavide correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy AT biunnoida correctionsel1lsnprs12435998apredictorofglioblastomasurvivalandresponsetoradiochemotherapy |